Investigational Site Number :0760001

Porto Alegre, Rio Grande do Sul 90610-000

0 studies enrolling now · 3 studies all time

What they study most

Plasma Cell Myeloma, Relapsing Multiple Sclerosis, Sphingomyelin Lipidosis

Studies at this site

• Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 2) — Completed
• Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) Patients — Completed
• A Prospective and Retrospective Cohort Study in Patients With Chronic Forms of Acid Sphingomyelinase Deficiency (ASMD) — Completed